Pencil beam algorithms are used to design patient treatment plans for proton therapy. Although these algorithms have been improved over the years, their fundamental approach will run into limitations to accurately describe beams that run tangential to boney structures or air cavities or have large density fluctuations along the beam path. Monte Carlo simulations are generally accepted to provide a more accurate description of particle tracks, especially with respect to multiple Coulomb scattering processes. The limitation for the general use of Monte Carlo simulations for treatment verifications in proton therapy has been the complexity of generating Monte Carlo simulations for each patient and the long time it takes to generate dose distributions.
We have utilized TOPAS to produce dose distributions for head and neck and compare them to the treatment planning system. TOPAS has been commissioned for the MGH proton therapy center. Ranges, modulation widths and field flatness are within clinical specifications and agree with water phantom measurements. Figure 1 shows the dose volume histograms for one selected patient (out of 21 patients that were analyzed) for the clinical target volume (CTV) and the gross tumor volume (GTV). The agreement is reasonable for the target volumes. However, dose differences of about 10% of the prescribed dose for 80% of critical volumes can be seen outside the target volume, especially at the end of beams. It is apparent that especially boney structures close to parallel to the incident beam path and air cavities in general produce such dose differences, as for the right optical nerve (see DVH). Figure 2 shows the DVH for another patient for the CTV and the chiasm. The extended range of the beam causes 70% of the chiasm to receive 10Gy where the pencil beam algorithm predicts nearly 0 dose, while the right optical nerve also receives an increased dose. Both are nevertheless still below clinical limits. A routine Monte Carlo dose verification for patients with complex geometries prior to treatment is therefore desirable. With the introduction of TOPAS, such verifications become possible for clinics without a dedicated research group. The results are equally applicable to other patient sites with complex geometries. 
